Ed is Professor of Medicine at the University of Auckland, New Zealand. Ed trained in hepatology at the Institute of Liver Studies, King’s College Hospital between 1992 and 1995, when he completed an MD thesis on recurrent hepatitis C following liver transplantation. In 1998, Ed was appointed as Chief Transplant Physician for the first New Zealand Liver Transplant programme at Auckland City Hospital.
Since 2000, Ed has been the Ministry of Health Clinical Advisor for the National Hepatitis B Screening and Follow-up Programme. In 2012, Ed was appointed as Hepatitis C Champion for the Ministry of Health. Ed serves on the Executive Committee of the NZ Society of Gastroenterology and is a member of several international organisations including APASL, AASLD, ILCA and ILTS.
Ed is lead investigator for two Health Research Council program grants which evaluate molecular predictors of hepatocarcinogenesis in Maori with childhood-acquired HBV. He is an investigator for many international clinical trials with particular interest in early phase development of new direct acting antiviral therapies against chronic hepatitis C and hepatitis B. Ed has published almost 300 papers in peer-reviewed journals including The Lancet and The New England Journal of Medicine.
In May 2011, Ed was awarded Member of the Order of New Zealand for Services to Medicine. In 2012, Ed received the Health Research Council’s Bevan Medal for outstanding research for his project entitled “Can better surveillance prevent liver cancer and death in Maori with chronic HBV”. In December 2014, Ed received the Royal Society’s Liley Medal for outstanding contribution to medical research in New Zealand for his work in developing new antiviral therapies for HCV. In November 2015, Ed was elected as a Fellow to the Royal Society of New Zealand. In February 2017, Ed was awarded the 2017 New Zealand Innovator of the Year for his work in HCV elimination in New Zealand